This study will develop an algorithm of identifying patients with stage IV NSCLC and Melanoma who could benefit from cancer treatment they receive.
Stage IV Non-small Cell Lung Cancer, Stage IV Malignant Melanoma, Stage IV Small Cell Lung Cancer, Stage III Malignant Melanoma
This study will develop an algorithm of identifying patients with stage IV NSCLC and Melanoma who could benefit from cancer treatment they receive.
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
-
Birmingham VAHCS, Birmingham, Alabama, United States, 35233
Mayo Clinic, Jacksonville, Florida, United States, 32224
University of Miami, Miami, Florida, United States, 33136
Florida Cancer Specialist and Research Institute, Orlando, Florida, United States, 32827
Protean Biodiagnosics, Orlando, Florida, United States, 32827
Northwest Community Healthcare, Rolling Meadows, Illinois, United States, 60008
Helen Nassif Community Cancer Center, Cedar Rapids, Iowa, United States, 52403
Rutgers Cancer Institute, New Brunswick, New Jersey, United States, 08903
Roswell Park, Buffalo, New York, United States, 14263
West Clinic, Germantown, Tennessee, United States, 38138
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
OncoHost Ltd.,
Alona Zer, MD, PRINCIPAL_INVESTIGATOR, 003 Rambam Medical Center
Michal Lotem, MD, PRINCIPAL_INVESTIGATOR, 001 Hadassah Medical Center
Jair Bar, MD, PRINCIPAL_INVESTIGATOR, 016 Sheba Medical Center
Maya Gottfried, MD, PRINCIPAL_INVESTIGATOR, 005 Meir Medical Center
Abed Agbaria, MD, PRINCIPAL_INVESTIGATOR, 004 Bnai Zion Medical Center
Ido Wolf, MD, PRINCIPAL_INVESTIGATOR, 002 Tel Aviv Sourasky Medical Center
Mahmud Abu-Amana, MD, PRINCIPAL_INVESTIGATOR, 007 Haemek Medical Center
Rivka Katsenelson, MD, PRINCIPAL_INVESTIGATOR, 008 Kaplan Medical Center
Alexander Yakobson, MD, PRINCIPAL_INVESTIGATOR, 009 Soroka Medical Center
Tatiana Harkovsky, MD, PRINCIPAL_INVESTIGATOR, 011 Barzilai Medical Center
Mor Moskovitz, MD, PRINCIPAL_INVESTIGATOR, 012 Rabin Medical Center
Elizabeta Dudnik, MD, PRINCIPAL_INVESTIGATOR, 013 Assuta Medical Center
Raya Leibowitz, MD, PRINCIPAL_INVESTIGATOR, 014 Shamir Medical Center
Adam Berger, MD, PRINCIPAL_INVESTIGATOR, 030 Rutgers Cancer Institute
Jose Lutzky, MD, PRINCIPAL_INVESTIGATOR, 032 University of Miami
Antony Magliocco, MD, PRINCIPAL_INVESTIGATOR, 015 Protean Biodiagnostics
Gillian Price, MD, PRINCIPAL_INVESTIGATOR, 020 Aberdeen Royal Infirmary
Helen Cheley, PRINCIPAL_INVESTIGATOR, 021 Swansea Bay UHB - Cancer Institute
Louise Medley, MD, PRINCIPAL_INVESTIGATOR, 022 Torbay and South Devon NHS foundation
Tom Geldart, MD, PRINCIPAL_INVESTIGATOR, 023 Royal Bournemouth General Hospital Dorset
Anirban Chatterjee, MD, PRINCIPAL_INVESTIGATOR, 024 The Shrewsbury and Telford Hospital
David Farrugia, MD, PRINCIPAL_INVESTIGATOR, 025 Cheltenham General Hospital
Andreas Polychronis, MD, PRINCIPAL_INVESTIGATOR, 026 Mount Vernon Cancer Centre
Andreas Polychronis, MD, PRINCIPAL_INVESTIGATOR, 027 Lister Hospital
Ari VanderWalde, MD, PRINCIPAL_INVESTIGATOR, 031 West Clinic
Davika Das, MD, PRINCIPAL_INVESTIGATOR, 033 VAHCS Birmingham
Alison Brewster, MD, PRINCIPAL_INVESTIGATOR, 051 Withybush Hospital Hawl Dda University Health Board
Adam Hassani, PRINCIPAL_INVESTIGATOR, 029 Sunderland Royal Hospital
Adam Hassani, MD, PRINCIPAL_INVESTIGATOR, 028 South Tyneside District
Andrew Conn, MD, PRINCIPAL_INVESTIGATOR, 050 Bradford Teaching Hospitals
Yanyan Lou, MD, PRINCIPAL_INVESTIGATOR, 034 Mayo Clinic
Igor Puzanov, MD, PRINCIPAL_INVESTIGATOR, 035 Roswell Park
Ernesto Bustinza, MD, PRINCIPAL_INVESTIGATOR, 153 Florida Cancer Specialists and Research Institute
Anita Sabichi, MD, PRINCIPAL_INVESTIGATOR, 036 Michael E Debakey VA Medical Center
Ronnie Shapira Frommer, MD, PRINCIPAL_INVESTIGATOR, 017 Sheba Medical Center
Ina Koch, PhD, PRINCIPAL_INVESTIGATOR, 040 Asklepios Klinik Gauting GmbH
Petros Christopoulos, MD, PRINCIPAL_INVESTIGATOR, 041 Thoraxklinik-Heidelberg gGmbH
Marina Messinger, MD, PRINCIPAL_INVESTIGATOR, 150 Northwest Community Healthcare
Sunil Patel, MD, PRINCIPAL_INVESTIGATOR, 151 CHRISTUS St. Michael Health System
William P Fusselman, MD, PRINCIPAL_INVESTIGATOR, 152 Physicians Clinic of Iowa
David Vecente, MD, PRINCIPAL_INVESTIGATOR, 044 Hospital Universitario Virgen Macarena
2029-10-01